BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

CELLDEX THERAPEUTICS, INC. — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

CELLDEX THERAPEUTICS, INC.

via AKIN GUMP STRAUSS HAUER & FELD

2nd Quarter (Apr 1 - June 30) · 2025Posted Jul 21, 2025Filing document ↗LDA record ↗

Income$60Kfee reported

Client

Name: CELLDEX THERAPEUTICS, INC.
Description: Biotechnology company developing therapeutics for patients.
Location: New Jersey · United States of America

Registrant

Firm: AKIN GUMP STRAUSS HAUER & FELD
Description: Law firm
Location: WASHINGTON, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Issues related to NIH-funded eosinophilic gastrointestinal disease research.
LobbyistsANNA ABRAM · KANDIS MCCLURE
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.